Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Amanda Pritchard Appointed NHS Chief Executive
Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]
Theme Park Joins NHS Covid Vaccine Drive
Thorpe Park Resort will today (Thursday) join the roll-call of iconic locations to take part […]
NHS Digital Launches Data Uses Register to Improve Transparency
NHS Digital is improving transparency about how patient data is accessed by launching its new […]
Avatar-led Programme for Kidney Disease Patients Expands After Successful Pilot
An avatar-led, interactive, information programme for people with Chronic Kidney Disease (CKD) has been so […]
Chelsea and Westminster Launch Acute Covid App for NHS Staff
Acute Covid was developed as part of the CW Innovation programme, which has been fast-tracking […]
Access to Genetic Results Allows for More Personalised Cancer Treatments
Doctors in Wales are now able to access digital genetic test results for urgent cancer […]
NHS England Announces New Innovative Medicines Fund to Fast-track Promising New Drugs
NHS patients are set to benefit from early access to potentially life-saving new medicines, including cutting-edge gene therapies, […]
Fully Vaccinated Critical Workers to be Able to Leave Self-isolation in Exceptional Circumstances
Railway signallers and air traffic controllers are among the critical workers who may in exceptional […]
UK to Roll Out Biggest Flu Programme in History for Winter 2021
Millions more people could benefit from a free flu vaccine this year, as the Health […]
Almost 100% of People Have Antibodies After Second Vaccine
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more